Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nacuity Pharmaceuticals, Inc.

Clinical trials sponsored by Nacuity Pharmaceuticals, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Eye implant may delay cataracts after vitrectomy Results expected Sep 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 2 Not yet finished but already full! 2 Completed 1

New pill aims to slow vision loss in rare usher syndrome

Disease control Completed

This study tests whether NPI-001 tablets can safely slow or stop vision loss in people with Usher syndrome, a rare genetic condition that causes blindness and hearing loss. About 49 adults will take either the study drug or a placebo for 24 months. The main goal is to see if the …

Phase 1/2 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jul 03, 2026 00:00 UTC